Point72 Europe (London) LLP Bio N Tech Se Transaction History
Point72 Europe (London) LLP
- $1.48 Billion
- Q3 2024
A detailed history of Point72 Europe (London) LLP transactions in Bio N Tech Se stock. As of the latest transaction made, Point72 Europe (London) LLP holds 27,231 shares of BNTX stock, worth $2.72 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
27,231Holding current value
$2.72 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
358Shares Held
38.4MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$828 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$450 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$435 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$189 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$180 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $24.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...